SCHERING-PLOUGH LEGISLATIVE RESOURCES L.L.C. for SCHERING-PLOUGH LEGISLATIVE RESOURCES L L C
A later version of this report replaces this one, so LegiList's totals use the current version instead. This page shows this version exactly as filed.
Versions of this report
Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.
| Filing | Filed | Amount | Counted |
|---|---|---|---|
| 3rd Quarter - Report (this page) | Oct 20, 2009 | $570,000 | Replaced |
| 3rd Quarter - Termination | Nov 18, 2009 | $330,000 | Yes |
What was lobbied
5 issue areas, each in the filer's own words, with who lobbied on it and where.
Copyright/Patent/Trademark CPT
H.R.1260, Patent Reform Act of 2009; H.R.1427, Promoting Innovation and Access to Life Saving Medicare Act; H.R.1548, Pathway for Biosimilars Act; H.R. 3200, America's Health Choice Act; S.369, Preserve Access to Affordable Generics Act; S.515, Patent Reform Act of 2009; S.610, Patent Reform Act of 2009; S.726, Promoting Innovation and Access to Life Saving Medicine Act; S._ _ _ (no number yet assigned), America's Health Choice Act. Legislative proposals effecting US patent system: H.R.1427, Promoting Innovations and Access to Life Saving Medicine Act; H.R.1548, Pathway for Biosimilars Act; S.726, Promoting Innovations and Access to Life Saving Medicine Act. Legislative proposals regarding follow-on biologics: H.R.1260, Patent Reform Act of 2009; H.R., 3200 America's Health Choice Act; S.515, Patent Reform Act of 2009; S.610, Patent Reform Act of 2009; S. _ _ _ (no number assigned yet), America's Health Choice Act. Legislative proposals regarding brand-generic drug firm agreements: S.369, Preserve Access to Affordable Generics Act.
| Lobbyist | Covered position, as disclosed |
|---|---|
| G LAWRENCE ATKINS | — |
| PAUL EHRLICH | — |
| ROBERT W LIVELY | — |
Health Issues HCR
H.R.1, American Recovery and Reinvestment Act of 2009; H.R.2, Children's Health Insurance Program Reauthorization Act of 2009; H.R.759, Food & Drug Administration Globalization Act of 2007; H.R.1298, Pharmaceutical Market Access and Drug Safety Act of 2009; S.525, Pharmaceutical Market Access and Drug Safety Act of 2009. Legislative proposals related to FDA oversight of drugs produced internationally: H.R.759, Food & Drug Administration Globalization Act of 2009. Legislative proposals permitting importation of prescription drugs from overseas: H.R.1298, Pharmaceutical Market Access and Drug Safety Act of 2009; S.525, Pharmaceutical Market Access and Drug Safety Act of 2009. Legislative proposals related to comparative effectiveness review: H.R.1, American Recovery and Reinvestment Act of 2009. Legislative proposals regarding health coverage: H.R.2, Pharmaceutical Market Access and Drug Safety Act of 2009. Response to congressional investigation regarding ENHANCE study.
| Lobbyist | Covered position, as disclosed |
|---|---|
| G LAWRENCE ATKINS | — |
| PAUL EHRLICH | — |
| ROBERT W LIVELY | — |
Taxation/Internal Revenue Code TAX
S.260. Legislative proposals regarding taxation of income of US corporations earned overseas: S.260.
| Lobbyist | Covered position, as disclosed |
|---|---|
| G LAWRENCE ATKINS | — |
| PAUL EHRLICH | — |
| ROBERT W LIVELY | — |
Medicare/Medicaid MMM
Legislative proposals that would incrase the Medicaid drug price rebate. (none yet introduced in this Congress)
| Lobbyist | Covered position, as disclosed |
|---|---|
| G LAWRENCE ATKINS | — |
| PAUL EHRLICH | — |
| ROBERT W LIVELY | — |
| ANGELA M STEWART New | — |
Labor Issues/Antitrust/Workplace LBR
H.R.2, Children's Health Insurance Program Reauthorization Act of 2009.
| Lobbyist | Covered position, as disclosed |
|---|---|
| G LAWRENCE ATKINS | — |
| PAUL EHRLICH | — |
| ROBERT W LIVELY | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.